Literature DB >> 20122814

Increased Maillard reaction products intake reduces phosphorus digestibility in male adolescents.

Cristina Delgado-Andrade1, Isabel Seiquer2, Marta Mesías García2, Gabriel Galdó3, M Pilar Navarro2.   

Abstract

OBJECTIVE: To examine the effects of consuming diets rich in Maillard reaction products (MRPs) on phosphorus bioavailability in male adolescents.
METHODS: A 2-wk randomized two-period crossover trial was performed among healthy male adolescents aged 11-14 y (n = 20), with a 40-d washout period. The diets consumed were rich (brown diet) or poor (white diet) in MRPs. Three-day balances were performed on the last of each dietary period, and fasting blood samples were obtained. Dietary phosphorus utilization was examined by phosphorus intake in diet and phosphorus output in feces and urine, as measured colorimetrically by the vanadomolibdate procedure. Serum phosphorus, parathyroid hormone, and total alkaline phosphatase were determined.
RESULTS: A tendency to increase daily phosphorus fecal excretion was observed subsequent to the brown diet consumption compared with the white diet (P = 0.10), which led to significant reductions in phosphorus apparent absorption (P = 0.03) and fractional absorption (P = 0.04). Values of apparent phosphorus retention and bioavailability tended to decrease after the high-MRP diet. Serum parameters analyzed remained unchanged between diets and were within normal values.
CONCLUSION: The consumption of a rich-MRP diet in male adolescents had a negative influence on dietary phosphorus absorption, tending to decrease the phosphorus balance. Given the actual dietary habits of adolescents, possible long-term repercussions of this kind of diet should be studied.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122814     DOI: 10.1016/j.nut.2009.10.009

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  8 in total

1.  Association between habitual dietary and lifestyle behaviours and skin autofluorescence (SAF), a marker of tissue accumulation of advanced glycation endproducts (AGEs), in healthy adults.

Authors:  Nicole J Kellow; Melinda T Coughlan; Christopher M Reid
Journal:  Eur J Nutr       Date:  2017-06-27       Impact factor: 5.614

Review 2.  Management of phosphorus load in CKD patients.

Authors:  Yutaka Taketani; Fumihiko Koiwa; Keitaro Yokoyama
Journal:  Clin Exp Nephrol       Date:  2016-11-28       Impact factor: 2.801

3.  Influence of bread crust-derived Maillard reaction products on phosphorus balance in rats.

Authors:  Irene Roncero-Ramos; Cristina Delgado-Andrade; Rebeca Alonso-Olalla; María Pilar Navarro
Journal:  Eur J Nutr       Date:  2011-11-01       Impact factor: 5.614

4.  Dietary phosphorus intake and blood pressure in adults: a systematic review of randomized trials and prospective observational studies.

Authors:  Scott T McClure; Casey M Rebholz; Sibyl Medabalimi; Emily A Hu; Zhe Xu; Elizabeth Selvin; Lawrence J Appel
Journal:  Am J Clin Nutr       Date:  2019-05-01       Impact factor: 7.045

Review 5.  Advanced glycation End-products (AGEs): an emerging concern for processed food industries.

Authors:  Chetan Sharma; Amarjeet Kaur; S S Thind; Baljit Singh; Shiveta Raina
Journal:  J Food Sci Technol       Date:  2015-08-01       Impact factor: 2.701

6.  Safety assessment of Maillard reaction products of chicken bone hydrolysate using Sprague-Dawley rats.

Authors:  Jin-Zhi Wang; Hong-Mei Sun; Chun-Hui Zhang; Li Hu; Xia Li; Xiao-Wei Wu
Journal:  Food Nutr Res       Date:  2016-03-23       Impact factor: 3.894

Review 7.  Maillard reaction products and potatoes: have the benefits been clearly assessed?

Authors:  DeAnn J Liska; Chad M Cook; Ding Ding Wang; John Szpylka
Journal:  Food Sci Nutr       Date:  2015-09-17       Impact factor: 2.863

Review 8.  Immunomodulation by Processed Animal Feed: The Role of Maillard Reaction Products and Advanced Glycation End-Products (AGEs).

Authors:  Malgorzata Teodorowicz; Wouter H Hendriks; Harry J Wichers; Huub F J Savelkoul
Journal:  Front Immunol       Date:  2018-09-13       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.